GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Nfkb2 | rn6_v1_chr1_+_266053002_266053002 | 0.77 | 4.8e-65 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr3_+_18315320 Show fit | 35.93 |
ENSRNOT00000006954
|
|
|
chr4_+_69384145 Show fit | 31.34 |
ENSRNOT00000084834
|
T cell receptor beta, variable 13-2 |
|
chr3_+_18706988 Show fit | 30.54 |
ENSRNOT00000074650
|
|
|
chr20_-_4070721 Show fit | 30.31 |
ENSRNOT00000000523
|
RT1 class II, locus Ba |
|
chr1_-_100537377 Show fit | 30.08 |
ENSRNOT00000026599
|
Spi-B transcription factor |
|
chr2_+_223121410 Show fit | 28.10 |
ENSRNOT00000087559
|
|
|
chr3_-_20695952 Show fit | 25.45 |
ENSRNOT00000072306
|
|
|
chr20_-_4921348 Show fit | 22.87 |
ENSRNOT00000082497
ENSRNOT00000041151 |
RT1 class I, locus CE4 |
|
chr1_-_89269930 Show fit | 22.20 |
ENSRNOT00000028532
|
free fatty acid receptor 2 |
|
chr20_+_5414448 Show fit | 21.52 |
ENSRNOT00000078972
ENSRNOT00000080900 |
RT1 class Ia, locus A1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 30.3 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.8 | 30.1 | GO:0030225 | macrophage differentiation(GO:0030225) |
8.7 | 26.0 | GO:0002876 | positive regulation of chronic inflammatory response to antigenic stimulus(GO:0002876) |
0.7 | 22.9 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.8 | 22.5 | GO:1902624 | positive regulation of neutrophil chemotaxis(GO:0090023) positive regulation of neutrophil migration(GO:1902624) |
5.6 | 22.2 | GO:0002232 | leukocyte chemotaxis involved in inflammatory response(GO:0002232) cell surface pattern recognition receptor signaling pathway(GO:0002752) regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
7.2 | 21.5 | GO:0002462 | tolerance induction to nonself antigen(GO:0002462) |
7.0 | 21.1 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
0.5 | 16.6 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
1.0 | 14.3 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.6 | 57.9 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.0 | 41.3 | GO:0005615 | extracellular space(GO:0005615) |
1.9 | 30.3 | GO:0042613 | MHC class II protein complex(GO:0042613) |
3.0 | 21.1 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.0 | 16.6 | GO:0005925 | focal adhesion(GO:0005925) |
1.6 | 14.3 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
1.5 | 13.2 | GO:0001940 | male pronucleus(GO:0001940) |
0.8 | 13.2 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
0.0 | 11.6 | GO:0009986 | cell surface(GO:0009986) |
0.2 | 10.8 | GO:0016328 | lateral plasma membrane(GO:0016328) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 43.8 | GO:0042605 | peptide antigen binding(GO:0042605) |
2.3 | 31.7 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.6 | 25.5 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.5 | 22.8 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
3.1 | 21.5 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
1.9 | 21.1 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.0 | 17.0 | GO:0008289 | lipid binding(GO:0008289) |
0.1 | 14.7 | GO:0019902 | phosphatase binding(GO:0019902) |
0.1 | 14.3 | GO:0001047 | core promoter binding(GO:0001047) |
2.7 | 13.4 | GO:0019862 | IgA binding(GO:0019862) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 35.9 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.5 | 27.7 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.4 | 16.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.3 | 14.7 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.3 | 14.3 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.4 | 13.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 13.2 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.4 | 13.0 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 12.7 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.3 | 9.2 | PID IL23 PATHWAY | IL23-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 31.7 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.8 | 31.1 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 22.2 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.2 | 13.0 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 10.0 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.4 | 6.1 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.3 | 4.9 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.0 | 4.1 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 3.9 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 1.1 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |